Published in J Clin Invest on February 01, 1973
Mechanism of suppression of vasopressin during alpha-adrenergic stimulation with norepinephrine. J Clin Invest (1974) 1.15
Mechanism of effect of hypoxia on renal water excretion. J Clin Invest (1978) 1.14
Mechanism of stimulation of vasopressin release during beta adrenergic stimulation with isoproterenol. J Clin Invest (1974) 1.09
Mechanism of effect of prostaglandin E 1 on renal water excretion. J Clin Invest (1973) 1.06
Mechanism of effect of thoracic inferior vena cava constriction on renal water excretion. J Clin Invest (1974) 1.03
Editorial: "Inappropriate" versus "appropriate" antidiuretic hormone secretion. West J Med (1974) 0.92
Effect of central catecholamine depletion on the osmotic and nonosmotic stimulation of vasopressin (antidiuretic hormone) in the rat. J Clin Invest (1979) 0.90
Modulation of the hydro-osmotic effect of vasopressin on the rabbit cortical collecting tubule by adrenergic agents. J Clin Invest (1983) 0.86
Prognostic value of hyponatremia in heart failure patients: an analysis of the Clinical Characteristics and Outcomes in the Relation with Serum Sodium Level in Asian Patients Hospitalized for Heart Failure (COAST) study. Korean J Intern Med (2015) 0.86
Outcomes of correcting hyponatremia in patients with myocardial infarction. Clin Res Cardiol (2013) 0.81
The physiology of vasopressin release and the pathogenesis of impaired water excretion in adrenal, thyroid, and edematous disorders. Yale J Biol Med (1981) 0.81
Studies of the mechanism of contralateral polyuria after renal artery stenosis. J Clin Invest (1977) 0.80
Functional characterization of the alpha adrenergic receptor modulating the hydroosmotic effect of vasopressin on the rabbit cortical collecting tubule. J Clin Invest (1984) 0.77
Molecular mechanisms of clinical concentrating and diluting disorders. Prog Brain Res (2008) 0.77
Hyponatremia Associated with Heart Failure: Pathological Role of Vasopressin-Dependent Impaired Water Excretion. J Clin Med (2015) 0.76
Head movement during low-frequency vibration. J Physiol (1975) 0.75
Non-osmotic regulation of renal water excretion. Trans Am Clin Climatol Assoc (1976) 0.75
A receptor mechanism for the inhibition of insulin release by epinephrine in man. J Clin Invest (1967) 3.48
The role of adenosine 3',5'-phosphate in the action of antidiuretic hormone. Am J Med (1967) 3.31
Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin. Science (1968) 2.90
An adrenergic receptor mechanism for the control of cyclic 3'5' adenosine monophosphate synthesis in tissues. Biochem Biophys Res Commun (1967) 2.55
Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs. Am J Physiol (1965) 1.87
The effect of epinephrine (USP), l-epinephrine, and l-norepinephrine on glomerular filtration rate, renal plasma flow, and the urinary excretion of sodium, potassium, and water in normal man. J Clin Invest (1952) 1.76
Mechanism of the antidiuretic effect associated with interruption of parasympathetic pathways. J Clin Invest (1972) 1.72
Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs. J Clin Invest (1970) 1.67
Mechanism of antidiuretic effect of beta adrenergic stimulation. J Clin Invest (1972) 1.54
Effect of adrenergic agents on toad bladder response to ADH, 3',5'-AMP, and theophylline. Am J Physiol (1968) 1.48
Stimulation of ADH release by the renin-angiotensin system. Am J Physiol (1970) 1.39
MECHANISM OF NATRIURESIS AND DIURESIS DURING ELEVATED RENAL ARTERIAL PRESSURE. Am J Physiol (1965) 1.29
Norepinephrine inhibition of vasopressin antidiuresis. J Clin Invest (1968) 1.26
Effect of adrenergic blocking agents on the vasopressin inhibiting action of norepinephrine. Proc Soc Exp Biol Med (1970) 1.12
Interrelated effects of antidiuretic hormone and adrenergic drugs on water metabolism. Am J Physiol (1971) 1.11
An effect of extrarenal beta adrenergic stimulation on the release of renin. J Clin Invest (1972) 1.10
Changes in sodium and water excretion induced by epinephrine and I-norepinephrine in normotensive and hypertensive subjects. J Lab Clin Med (1963) 1.09
Mechanism of effect of prostaglandin E 1 on renal water excretion. J Clin Invest (1973) 1.06
Factors involved in antinatriuretic effects of acute constriction of the thoracic and abdominal inferior vena cava. Circ Res (1971) 1.03
Tyramine, catecholamines and the action of vasopressin on stimulation of water efflux in toad bladders. Arch Biochem Biophys (1969) 1.00
The effects of changes in the rate of infusion of vasopressin in anesthetized dogs. Can J Physiol Pharmacol (1971) 0.96
Importance of sodium intake and mineralocorticoid hormone in the impaired water excretion in adrenal insufficiency. J Clin Invest (1972) 0.90
Observations on a central antagonism between adrenaline and acetylcholine. J Physiol (1956) 0.86
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med (1998) 7.18
Sodium. Lancet (1998) 3.38
The human costs of tobacco use (1) N Engl J Med (1994) 3.24
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest (2001) 2.84
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.82
Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med (1985) 2.82
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care (2000) 2.36
Osmotic and nonosmotic control of vasopressin release. Am J Physiol (1979) 2.18
Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med (1978) 2.13
We're at war--but where are our troops? Hosp Pract (Off Ed) (1994) 2.01
The human costs of tobacco use (2) N Engl J Med (1994) 1.93
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2000) 1.86
Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. J Clin Invest (1975) 1.85
Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med (1987) 1.76
Mechanism of the antidiuretic effect associated with interruption of parasympathetic pathways. J Clin Invest (1972) 1.72
Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs. J Clin Invest (1970) 1.67
Nonoliguric acute renal failure. N Engl J Med (1977) 1.64
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int (1998) 1.64
Unrecognized adult salicylate intoxication. Ann Intern Med (1976) 1.63
Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1994) 1.61
Altered water metabolism in tuberculosis: role of vasopressin. Am J Med (1990) 1.60
"Beer potomania" in non-beer drinkers: effect of low dietary solute intake. Am J Kidney Dis (1998) 1.59
Mechanism of antidiuretic effect of beta adrenergic stimulation. J Clin Invest (1972) 1.54
Postoperative hyponatremia. A prospective study. Arch Intern Med (1986) 1.50
Role of vasopressin in the impaired water excretion of glucocorticoid deficiency. Kidney Int (1980) 1.50
Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med (1981) 1.49
Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med (1982) 1.48
The effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a pooled analysis of individual-patient data from 11 randomized, controlled trials. Ann Intern Med (2001) 1.44
Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease. Ann Intern Med (1991) 1.44
Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int (2001) 1.41
Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care (1996) 1.40
Infusion of glycine does not attenuate in vivo ischemic acute renal failure in the rat. J Lab Clin Med (1993) 1.40
Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med (1988) 1.40
Health care reform at $2 a pack. Hosp Pract (Off Ed) (1993) 1.39
Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis (1999) 1.37
Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1997) 1.37
Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med (1998) 1.36
Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int (1990) 1.36
Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis (1998) 1.32
Renal tubular acidosis associated with toluene "sniffing". N Engl J Med (1974) 1.32
Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat. Am J Physiol (1977) 1.32
Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol (2001) 1.29
Polyuria of thyrotoxicosis: downregulation of aquaporin water channels and increased solute excretion. Kidney Int (2007) 1.28
Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology (1998) 1.27
Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol (1997) 1.26
Upregulation of aquaporin-2 water channel expression in chronic heart failure rat. J Clin Invest (1997) 1.25
Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Intern Med (1982) 1.24
In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin. J Clin Invest (1977) 1.24
The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int (1989) 1.24
Loop diuretic infusion increases thiazide-sensitive Na(+)/Cl(-)-cotransporter abundance: role of aldosterone. J Am Soc Nephrol (2001) 1.23
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int (1996) 1.20
Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci U S A (1994) 1.20
Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am J Physiol Renal Physiol (2000) 1.18
Diagnostic importance of an increased serum anion gap. N Engl J Med (1980) 1.18
Renal, metabolic, and circulatory responses to heat and exercise. Studies in military recruits during summer training, with implications for acute renal failure. Ann Intern Med (1970) 1.18
Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail (1998) 1.17
Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int (1986) 1.16
Effect of beta-adrenergic blockade and inhibitors of angiotensin II and prostaglandins on renal autoregulation. Am J Physiol (1975) 1.16
Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest (1988) 1.15
Mechanism of suppression of vasopressin during alpha-adrenergic stimulation with norepinephrine. J Clin Invest (1974) 1.15
Mechanism of increased sodium reabsorption during propranolol administration. Circulation (1971) 1.14
Mechanism of effect of hypoxia on renal water excretion. J Clin Invest (1978) 1.14
Effects of vitamin D-induced chronic hypercalcemia on rat renal cortical plasma membranes and mitochondria. Am J Physiol (1987) 1.14
On the mechanism of polyuria in potassium depletion. The role of polydipsia. J Clin Invest (1977) 1.13
Sodium, potassium and water metabolism in the syndrome of inappropriate antidiuretic hormone secretion. Am J Med (1970) 1.12
Renal cell carcinoma: unusual systemic manifestations. Medicine (Baltimore) (1976) 1.11
Pathogenesis and management of hyponatremia. Am J Med (2000) 1.11
Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology (1995) 1.11
The renal risks of smoking. Kidney Int (1997) 1.10
An effect of extrarenal beta adrenergic stimulation on the release of renin. J Clin Invest (1972) 1.10
Dominant-negative c-Jun NH2-terminal kinase 2 sensitizes renal inner medullary collecting duct cells to hypertonicity-induced lethality independent of organic osmolyte transport. J Biol Chem (1998) 1.09
Mechanism of stimulation of vasopressin release during beta adrenergic stimulation with isoproterenol. J Clin Invest (1974) 1.09
The global tobacco epidemic. Sci Am (1995) 1.07
Mechanism of effect of prostaglandin E 1 on renal water excretion. J Clin Invest (1973) 1.06
The nature of renal cell injury. Kidney Int (1997) 1.06
Protective effect of intrarenal calcium membrane blockers before or after renal ischemia. Functional, morphological, and mitochondrial studies. J Clin Invest (1984) 1.06
VEGF receptor inhibition slows the progression of polycystic kidney disease. Kidney Int (2007) 1.06
Role of caspases in hypoxia-induced necrosis of rat renal proximal tubules. J Am Soc Nephrol (1999) 1.04
Nephropathy associated with heat stress and exercise. Ann Intern Med (1967) 1.04
Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology (1996) 1.04
Role of cardiac output and the autonomic nervous system in the antinatriuretic response to acute constriction of the thoracic superior vena cava. Circ Res (1971) 1.04
Pathogenic mechanisms in early norepinephrine-induced acute renal failure: functional and histological correlates of protection. Kidney Int (1978) 1.03
Mechanism of effect of thoracic inferior vena cava constriction on renal water excretion. J Clin Invest (1974) 1.03
Factors involved in antinatriuretic effects of acute constriction of the thoracic and abdominal inferior vena cava. Circ Res (1971) 1.03
Renal toxicity in uranium mill workers. Scand J Work Environ Health (1985) 1.03
Determinants of survival and recovery in acute renal failure patients dialyzed in intensive-care units. Am J Nephrol (1991) 1.03
1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study. Ann Intern Med (1978) 1.02